SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (87)2/5/1997 3:18:00 PM
From: James Silverman   of 1115
 
I think that antisense tech. may eventually be better, but I really doubt that the FDA will allow messing with DNA and RNA for oral herpes until antisense side-effects can be assessed.
=====================
John-one last time, the drug in question is not an antisense drug. Forvade synthesizes the DNA of the VIRUS. Go over your posts again, I understood you loud and clear. LDAK is now pursuing the same strategy of filing initially for AIDS patients with compromised immune systems. Or at least thats what was included in their latest FDA filings-if I am reading them properly :-)

Another question for you to help value LDAK, what are the terms to their agreement with BMY? Are they a royalty deal/joint marketing? If royalty, what percent are they looking at?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext